Beware of boilerplate: Practical lessons for patent drafting from G1/24 (Claim interpretation)
Following the high profile hearing last month, we are now all waiting with bated breath for the written decision of the Enlarged Board of...
top of page
G 2/21 applied to software inventions (T 0687/22)
The EPO Board of Appeal decision in T 0687/22 confirms beyond doubt the relevance of G 2/21 to software inventions. The decision in ...
Use versus process patents: Implications for novelty and scope (T 1913/21)
The recent decision T 1913/21 highlights a crucial differentiation between second non-medical use claims and process claims. The Board...
Too broad, too early? AI platform for cell analysis found to lack technical character and sufficiency (T 0660/22, Cell analysis/NIKON)
The decision in T 0660/22 combines two hot topics, AI and cells! The patent application at issue related to a method for analysing...
To infinity and beyond! The sufficiency requirements for open-ended ranges (T 1977/22)
The recent Board of Appeal decision in T 1977/22 related to the patentability of claims defining subject matter with open-ended...
Functional claims for pharmaceutical formulations: Validity versus enforcement (T 2130/22)
The Board of Appeal decision in T 2130/22 considered the inventive step of a pharmaceutical formulation in which the technical effect...
Falling between the cracks: The challenges of patent strategy for stem cell therapies (T 1259/22)
Cell therapy is a highly innovative therapeutic strategy that uses living cells to combat disease. Cell therapy strategies include stem...
The benefits and pitfalls of drug manufacturing IP (T 2543/22)
The Board of Appeal decision in T 2543/22 relates to a manufacturing method for preparing a therapeutic peptide. The Board of Appeal...
A new mode of administration is a new specific medical use (but not necessarily inventive) (T 0295/22)
The Board of Appeal decision in T 0295/22 tackles the question of whether a new mode of administration of a drug should be considered a...
EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation"
The Enlarged Board of Appeal (EBA) has issued its preliminary opinion in the closely watched referral G1/24 relating to the role of the...
bottom of page